VOLITIONRX LTD
For the period ended Mar 31, 2026. Filed May 14, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 14, 2026
VNRX$0.18-7.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Operations and Comprehensive Loss
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)
| Three Months EndedMarch 31, | ||
|---|---|---|
| 2026 | 2025 | |
| $ | $ | |
| Revenues | ||
| Service | 58,949 | 115,476 |
| Product | 926,127 | 130,909 |
| Total Revenues | 985,076 | 246,385 |
| Operating Expenses | ||
| Research and development | 2,852,251 | 2,607,444 |
| General and administrative | 2,629,826 | 2,243,362 |
| Sales and marketing | 851,851 | 917,299 |
| Total Operating Expenses | 6,333,928 | 5,768,105 |
| Operating Loss | (5,348,852) | (5,521,720) |
| Other Income (Expense) | ||
| Grant income | 120,531 | 121,566 |
| Interest income | 16 | 158 |
| Interest expense | (125,842) | (96,669) |
| Amortization of debt discount | (450,134) | - |
| Gain on change in fair value of warrant liability | 13,416 | 20,038 |
| Gain on change in fair value of derivative liability | 98,642 | - |
| Loss on extinguishment of debt | (1,011,334) | - |
| Total Other Income (Expenses) | (1,354,705) | 45,093 |
| Net Loss | (6,703,557) | (5,476,627) |
| Net Loss Attributable to Non-Controlling Interest | 38,783 | 52,868 |
| Net Loss Attributable to VolitionRx Stockholders | (6,664,774) | (5,423,759) |
| Other Comprehensive Income (Loss) | ||
| Foreign currency translation adjustments | 134,307 | (253,929) |
| Net Comprehensive Loss | (6,569,250) | (5,730,556) |
| Loss Per Common Share – Attributable to Common Stockholders - Basic and Diluted | (0.97) | (1.12) |
| Weighted Average Shares Outstanding – Basic and Diluted | 6,882,744 | 4,826,803 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.